Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Jordan VC.

Breast Cancer Res Treat. 1982;2(2):123-38. Review.

PMID:
6184101
2.
3.

Pharmacology of tamoxifen in laboratory animals.

Jordan VC, Allen KE, Dix CJ.

Cancer Treat Rep. 1980 Jun-Jul;64(6-7):745-59. Review.

PMID:
6775807
4.
5.

Species-specific pharmacology of antiestrogens: role of metabolism.

Jordan VC, Robinson SP.

Fed Proc. 1987 Apr;46(5):1870-4.

PMID:
3556610
8.

Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens in vitro.

Lieberman ME, Jordan VC, Fritsch M, Santos MA, Gorski J.

J Biol Chem. 1983 Apr 25;258(8):4734-40.

10.

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.

Jordan VC, Collins MM, Rowsby L, Prestwich G.

J Endocrinol. 1977 Nov;75(2):305-16.

PMID:
591813
11.
12.

Basic guide to the mechanisms of antiestrogen action.

MacGregor JI, Jordan VC.

Pharmacol Rev. 1998 Jun;50(2):151-96. Review.

13.
14.

[The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen].

Borgna JL.

Bull Cancer. 1994 Jan;81(1):29-37. Review. French.

PMID:
7949581
15.

Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.

Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL.

Chem Res Toxicol. 2003 Jul;16(7):832-7.

PMID:
12870885
16.

Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer.

Langan-Fahey SM, Tormey DC, Jordan VC.

Eur J Cancer. 1990;26(8):883-8.

PMID:
2145931
17.

Identification and biological activity of tamoxifen metabolites in human serum.

Kemp JV, Adam HK, Wakeling AE, Slater R.

Biochem Pharmacol. 1983 Jul 1;32(13):2045-52.

PMID:
6870933
18.

Cellular and molecular mechanism of action of antiestrogens.

Rochefort H, Borgna JL, Evans E.

J Steroid Biochem. 1983 Jul;19(1A):69-74.

PMID:
6887874
19.
20.

MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.

BrĂ¼nner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua SA, Clarke R.

Cancer Res. 1997 Aug 15;57(16):3486-93.

Supplemental Content

Support Center